Compare Hubbell (HUBB) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hubbell vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Hubbell trades at $474.11 (market cap $25.12B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Hubbell and Royalty Pharma plc Class A Ordinary Shares are close in size by market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Hubbell for 4 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| HUBB | RPRX | |
|---|---|---|
Market Cap | $25.12B | $25.27B |
Volume | 784,557 | 3,671,183 |
Sector | Industrials | Health |
52-Week High | $557.85 | $63.96 |
52-Week Low | $407.36 | $35.44 |
Typical Hold Time | 4 Days | 1 Days |
Enterprise Value | $30.28B | $32.50B |
Dividend Yield | 1.19% | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hubbell
Hubbell manufactures electrical and utility products used in transmission, distribution, and electrical infrastructure. Its portfolio includes components and systems for utilities, data centers, industrial facilities, and buildings.
Read more on HUBB →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
